M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.52 EUR -3.34% Market Closed
Market Cap: 104.5m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

Maat Pharma SA
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Maat Pharma SA
Net Income Peer Comparison

Comparables:
VLA
G
GNFT
IVA
ALERS
OSE

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
M
Maat Pharma SA
PAR:MAAT
Net Income
-€19.7m
CAGR 3-Years
-55%
CAGR 5-Years
-35%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Net Income
-€32.4m
CAGR 3-Years
36%
CAGR 5-Years
N/A
CAGR 10-Years
-1%
G
Genfit SA
PAR:GNFT
Net Income
€22.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Inventiva SA
PAR:IVA
Net Income
-€110.4m
CAGR 3-Years
-39%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
Eurobio Scientific SA
PAR:ALERS
Net Income
€4.8m
CAGR 3-Years
-61%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
OSE Immunotherapeutics SA
PAR:OSE
Net Income
€46m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Maat Pharma SA's Net Income?
Net Income
-19.7m EUR

Based on the financial report for Dec 31, 2023, Maat Pharma SA's Net Income amounts to -19.7m EUR.

What is Maat Pharma SA's Net Income growth rate?
Net Income CAGR 5Y
-35%

Over the last year, the Net Income growth was -44%. The average annual Net Income growth rates for Maat Pharma SA have been -55% over the past three years , -35% over the past five years .

Back to Top